Our Publication  

• 7Sep

  Indian Government invites comments to regulate e-pharmacies

  RNA IP  Comments (0)

  The online pharmacy business is currently estimated to be worth Rupees 3000 crores (approx US $ 400 million) and sales are growing 100 per cent every year. E-pharmacies have been lobbying with the government to acknowledge online...
  27Aug

  Court frowns upon practice of blow hot and cold

  RNA IP  Comments (0)

  Can you question novelty of design as a defence to infringement action? What is the impact of defendant seeking registration of a design and later claiming it lacks novelty? These among other issues were subject...
• 31Jul

  Prior use saves the day for Sun

  RNA IP  Comments (0)

  This post discusses the tussle between two well established pharmaceutical companies in relation to trademark being used on a diabetic drug. The Plaintiff, Sun Pharma Laboratories Ltd, (Sun) filed the action before the Delhi High...
  27Jul

  SEP holders rejoice over Delhi High Court Ruling

  RNA IP  Comments (0)

  The Delhi High Court’s recent decision determining infringement of the Patent owned by Philips that were declared as Standard-Essential Patent (SEP) by European Patent office and US. Thus axiomatically an essential Patent in India has...
• 24Jul

  Use of family name held to be non-infringing “fair use”

  RNA IP  Comments (0)

  The parties are at loggerheads over use of family name PATIL in relation to fragrance business. The first round of litigation was before the District court, Bengalaru and the parties have now approached Karnataka High...
  9Jul

  India promises market potential but challenges remain for luxury brands

  RNA IP  Comments (0)

  While luxury brands are increasingly entering the Indian market, proving India’s potential as a destination for luxury products, they face some formidable challenges, including high import duties, lack of quality retails space and the ever-present...